RemSleep Holdings Inc (PK) (RMSL)

RMSL (legit sleep app company)....rumor is they are about to complete a M&A with another company. Which would explain the late filing and the buying Friday.

RMSL. I have been slowly rebuying as there is no possible dilution until early July at the earliest. Down from .008s to .002s despite the fact that their PAP devices are now being sold. Bringing in revs for the first time in company history and it has the highest reviews on the socials.

No brainer here imo.

https://www.otcmarkets.com/stock/RMSL/news/REMSleep-Holdings-Announces-Full-Commercial-Launch-of-DeltaWaveTM?id=511637

Shoulder forming nice.

Looks like dilution started today from that Aug 15 convertible loan. Some avg/T trades going through. Not sure why it was delayed 10 days or so.

RMSL Next round of dilution starts this Weds. Diagonal (the financier) will get shares around .004 or so. Which means they have to sell roughly 15-20 M shares to cover their Aug 15 loan. You will know when the dilution starts when you start to see the T trades AH. Will be interesting to see how they handle it this time. Last loan in Dec/Jan they hammered the stock down to .0012. Shouldn't go that low this time obviously as they are getting their shares at higher VWAP.

Not a scam. I am a big believer in their product. I am surprised that this has held up so well with dilution coming again in a few days from the August 15 2025 loan. From what we have seen the MMs start to short the stock about a week before each loan comes due. Which in this case I believe is around Feb 8. Each time they have done a loan with this company and it matured...Diagonal Lending....the stock has fallen quite a bit. Hence the 90% decline over the past year.

The only good thing is the stock is higher now compared to the last convertible, so it won't take as much diluted shares to pay off the debt.

Beast. 🎅

Is this scam still running? Now 6 years since the post of mine I replied to, and they're still pretending to be a company, selling stock, and paying themselves handsome wages.

Nice little bounce back today.

There is going to be some dilution and probably some NSS starting soon. The next tranche of dilution for $63 K starts Feb 11. Hopefully it will hold this .004 area as it could cut down on the amount of shares that are shoved into the OS.

wow this died all of a sudden

GM Threeflight and all:)

This is the RemSleep board...

This is NOT the place to discuss DBMM... and I'm done conversing about it here.

So what makes DBMM objectively worse than this company? To merit most of your time criticizing them?

A good trader 🤣

It only makes YOU go hmmm...

Got a tip from a good trader, bought it, made money!

Maybe try it sometime?

Doesn't the SEC have Kramer on a short leash these days?

But this company has an active convertible note with Kramer. Yet most of your attention is spent on a company who's last note with the Kramers was over 10 years ago?? Thing that make one go hmmmm...

Got a low volume red day out of the way

Good evening. Nice consolidation day.

There are only so many hours in a day...

Feel free to point it out wherever you find it!

Than why did you not bring it up here? Isn't that what you do? Try to protect people?

..wow .0066 only showed like 200,000 but a million was sold into the BID.

Didnt move it! That and the BID grew and more BIDS popped up…i think we are being ‘FDA’ loaded brotha!

..could now be the best sleep apnea tech in all of biotech. Latest and greatest, easier to breathe and the only flexible side sleeping hose tech>?

Hard to price this…but it aint subpenny….new FDA clearance just tripled their customer base. This could, as weve seen, out of nowhere massive volume and boom penny break.

Good morning brother! 

Convertible debt is bad. All traders should take that into consideration when speculating!

SEEMS LIKE YOU ARE STARTING TO GET IT!

Congrats all on the great move and news! REMSleep Receives Expanded FDA 510(k) Clearance for DeltaWave Nasal Pillow System
Supplemental Clearance Opens Institutional Markets and Expands Patient Population Beyond Traditional CPAP Therapy

BLACKSHEAR, GA - January 15, 2026 (NEWMEDIAWIRE) - REMSleep Holdings, Inc. (OTCQB: RMSL), developer of the FDA-cleared DeltaWave(TM) nasal pillow system, today announced receipt of expanded 510(k) clearance (K253939) from the U.S. Food and Drug Administration. The approval, granted January 15, 2026, significantly broadens DeltaWave's indicated use beyond home-based CPAP therapy to include institutional settings and a wider range of patient populations.

The expanded clearance represents a direct response to feedback from early adopters during REMSleep's Q4 2025 soft launch. Healthcare providers reported that patients in different care settings - hospitals, long-term care facilities, rehabilitation centers, and sleep labs - could benefit from DeltaWave but were restricted by the original clearance language.

"Our customers told us they were seeing patients who needed what DeltaWave offers but couldn't access it because of how narrowly we'd written the original 510(k)," said Thomas Wood, CEO and founder of REMSleep. "Sleep technicians, pulmonologists, and respiratory therapists work with these patients every day. When they tell us there's a clinical need, we listen."

What Changed:

The original 510(k) clearance, granted in 2024, limited DeltaWave to home use with continuous positive airway pressure (CPAP) devices for obstructive sleep apnea treatment. The supplemental clearance expands the indicated use in two critical ways:

Settings: DeltaWave is now cleared for use in hospitals, long-term care facilities, rehabilitation centers, sleep laboratories, and other institutional environments for single-patient use. Previously restricted to home care settings only.

Patient Populations and Device Modalities: The expanded clearance covers use with all non-invasive positive airway devices. This opens DeltaWave to patients with central sleep apnea, complex sleep apnea, congestive heart failure, neuromuscular diseases, and COPD - conditions requiring more modalities and therapy than traditional CPAP.

Why This Matters:

The expanded clearance addresses three strategic opportunities that surfaced during REMSleep's market entry:

Institutional Sales Channel: Hospitals and long-term care facilities struggle to find the right fit and function for patients so they can transition to the next care setting. DeltaWave will offer a great option for physicians and respiratory therapists to provide comfortable therapy.

Diagnostic Titration Settings: Sleep laboratories conduct overnight studies where patients are fitted with masks and pressure settings are calibrated. Lab technicians requested access to DeltaWave for patients struggling with traditional interfaces during diagnostic sessions. The expanded clearance allows DeltaWave use during titration studies, creating opportunities for patients to experience the device before going home.

Complex Patient Populations: Patients with congestive heart failure, COPD, or neuromuscular diseases often require BiPAP or ventilation modalities. These patients frequently experience mask fit challenges that can lead to therapy abandonment. DeltaWave's direct-flow technology and flexible pillow design address comfort issues particularly acute in these medically fragile populations.

Customer-Driven Development:

REMSleep submitted the supplemental 510(k) application in early December 2025 after consolidating feedback from early adoption partners. The feedback was consistent: the device was performing well clinically, but the narrow indicated use created barriers to broader adoption.

"You asked, we listened," Wood said. "That's not marketing speak. We had sleep lab directors, hospital respiratory therapists, and DME providers all telling us the same thing - patients in their care settings needed access to this device. Our job was to work through the regulatory process to make that happen."

Market Implications:

The expanded clearance positions REMSleep to execute on all three channels outlined in the company's Q1 2026 strategy announced December 30:

- DME/HME providers can now position DeltaWave as a rescue mask for patients failing traditional interfaces across all pressure modalities, not just CPAP.

- Sleep laboratories and pulmonologists can introduce patients to DeltaWave during diagnostic titration, creating brand preference before patients enter the home care channel.

- Institutional sales teams can now approach hospital respiratory departments, long-term care facilities, and rehabilitation centers with a device cleared for their patient populations and care environments.

"The timing is deliberate," Marshall said. "We spent Q4 building infrastructure - sales force, inventory systems, replacement parts. Now we have the regulatory clearance to support the full strategy. Everything's aligned."

Next Steps:

REMSleep will update marketing materials, sales training, and product labeling to reflect the expanded indicated use. The company is notifying existing partners and potential institutional customers about the expanded clearance.

The expanded 510(k) clearance is publicly available in the FDA's 510(k) Premarket Notification database under device number K253939.

About REMSleep Holdings, Inc.

REMSleep Holdings, Inc. (OTCQB: RMSL) is a medical device company focused on improving outcomes for patients requiring positive airway pressure therapy. The company's DeltaWave(TM) nasal pillow system is FDA-cleared for use with CPAP, BiPAP, and other non-invasive positive pressure devices in both home and institutional settings. The system is designed to address common compliance challenges through its patented direct-flow interface technology.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including but not limited to: market acceptance of the DeltaWave system across multiple channels and care settings, the company's ability to penetrate institutional markets, the development of distribution partnerships, and general market conditions. REMSleep undertakes no obligation to update these forward-looking statements.

Contact:
Thomas Wood, CEO
REMSleep Holdings, Inc.
912-590-2001
twood@remsleep.com

https://stockinvest.us/digest/remsleep-fda-cleared-deltawave-but-negligible-sales-heavy-convertible-debt-and-going-concern

Link?

Really you criticised Linda Perry for choosing the Kramers for financing, well this company has convertible notes with Kramer currently.

Good afternoon. Sorry I missed the morning greeting haha.

I only got in earlier this week. But yeah probably. Multi penny run coming IMO

…yeah isnt this a huge deal? havent they worked on this for like 10 years? They not only just tripled their possible customer base, but the FDA gave them this green light-?

So the FDA basically gave their DeltaWave Nasal Pillow System, a big stamp of approval. Being this is now the newest FDA sleep apnea and other sleep condition, approval, it then makes it the best sleep apnea tech …in the world?

Can someone who knows the story better here clarify…..again, isnt this all a huge deal for a subpenny stock?Wouldnt this create quite a stir to Naz biotech and other investors who may find this? Isnt this the kind of news where people can and will buy as much as they can subpenny for longer?

sell the FDA news? wtf are we doing OTC?

This one went berserks

Significantly expands the potential market...

here ya go:
https://www.nasdaq.com/press-release/remsleep-receives-expanded-fda-510k-clearance-deltawave-nasal-pillow-system-2026-01

AI states that company is releasing news Jan.15 , 2026 ! That's today folks !

510k fda approval no pr out yet per th

I have no idea what you are babbling about...

It's always great to be riding another monster with you buddy woohoo 🎉 

GM brother 

What about the reverse split in 2015 and 2017? What about the dilution? What about the convertible note with 1800 diagonal Kramers?

What about pumpers? If they are lying, they should be "gone after"!

What is your point?

Wait what about going after pumpers?

Another solid day for RMSL. Quite a turnaround the past few days. I would expect some consolidation at some point after this rocket move but things are looking bright in the near and long term.

Bingo. :)

Lfg!!

you always show up on new Winners...LOL

GM threeflight! Bring on the pennyland fun 🤩 

Yes, and thank you!